CDH2 and cancer: As EMT progresses, overall mesenchymal markers (Figure 1B) such as vimentin and N-cadherin are upregulated, while the expression of epithelial markers such as E-cadherin decreases, leading to increased cancer cell motility and invasion (recently summarized by us in [24]).